Resistance of Targeted Therapies Excluding Antibodies for Lymphomas

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Ferreri, Andrés J. M. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2018.
• Έκδοση: 1st ed. 2018.
• Σειρά: Resistance to Targeted Anti-Cancer Therapeutics, 17
• Θέματα: Cancer research.; Molecular biology.; Cancer Research.; Molecular Medicine.
• Φυσική περιγραφή: XIII, 138 p. 14 illus., 13 illus. in color. online resource.
• ISBN: 9783319751849
• ISSN: 2196-5501 ;
• DOI: 10.1007/978-3-319-75184-9

In the last decade, the literature on molecular mechanisms and activated pathways in the different lymphoma categories increased exponentially, which was followed by a more diffuse and successful use of targeted therapies. In this book, expert authors revisit the most relevant aspects of these therapies, with special emphasis on molecular mechanisms and clinical effects of resistance. The knowledge of the underlying mechanisms involved in tumor resistance to target therapies is of paramount importance because they will result in a better selection of patients with sensitive disease and the establishment of suitable combinations of drugs that target different molecules and could overcome the established resistance. .